Enhabit Strategy and Business Model

Executive Overview

Enhabit is a U.S. home-based care company focused on two adjacent services: Medicare-certified home health and hospice. Headquartered in Dallas, Texas, the company became an independent public company in July 2022 when Encompass Health spun off its home health and hospice business. Enhabit operates in the post-acute and end-of-life care market, where demand is supported by an aging population, payer interest in lower-cost care settings, and patient preference for receiving care at home.

Its home health business provides skilled nursing, therapy, and other clinically supervised services to patients recovering from illness, injury, or surgery. Its hospice business supports patients with terminal illness through interdisciplinary end-of-life care, symptom management, and family support. Enhabit’s footprint spans 34 states, giving it national reach without being fully nationwide. The company reported fiscal 2024 revenue of just over $1.0 billion.

Strategically, Enhabit is trying to do three things at once: restore stronger home health growth, keep building hospice scale, and improve margins through better labor productivity, sales execution, and operating discipline. That makes it a useful case study in a labor-intensive, regulation-heavy healthcare services business where local execution matters as much as corporate strategy.

Enhabit at a Glance

Logo
Common name	Enhabit
Full legal name	Enhabit, Inc.
Headquarters	Dallas, Texas, United States
Ownership	Public company; widely held public-market ownership
Ticker	EHAB
Exchange	NYSE - New York Stock Exchange
Market Cap	#N/A
Revenue (FY2024)	#N/A
Founding / major historical milestones	Independent public company since July 2022; spun off from Encompass Health’s home health and hospice business
Industry or industries	Home health, hospice, post-acute care, healthcare services
Key products or services	Home health nursing and therapy; hospice care; related clinical and support services delivered in the home
Geographic footprint	United States; multi-state operating footprint across 34 states
Business segments as officially reported	Home Health; Hospice
Company website	https://www.ehab.com/

1. What Is the Strategy of Enhabit?

Using the Playing to Win framework, Enhabit’s strategy can be understood as an effort to build a stronger home-based care platform by pairing national scale with local branch execution. In its FY2024 disclosures and 2024-2025 earnings commentary, management emphasized growth recovery in home health, continued hospice expansion, labor stability, and margin improvement.

1a. What is the winning aspiration of Enhabit?

Enhabit’s practical aspiration is to be a high-quality, cost-effective provider of care in the home for post-acute and end-of-life patients, while restoring sustainable growth and profitability as a standalone company. Public commentary suggests that “winning” is not just about being large; it is about becoming a more consistently growing and better-margin operator in home health and hospice. Since the spin-off, management has focused on rebuilding operational momentum, especially in home health, while preserving hospice growth and improving cash generation.
1b. Where does Enhabit play?

Enhabit plays in U.S. home-based healthcare, specifically in two regulated service lines: home health and hospice. It serves mostly older adults and other eligible patients who can receive clinically appropriate care at home. The company does not try to compete across the full healthcare continuum; it is concentrated in home-based services reimbursed largely by Medicare and, to a lesser extent, Medicare Advantage, Medicaid, commercial plans, and other payers. Geographically, it operates across 34 states, with a branch-based model that depends on local density and referral relationships rather than nationwide coverage in every market.
1c. How does Enhabit plan to win?

Enhabit’s path to winning appears to rest on four levers. First, it aims to deliver clinically reliable care with strong quality and compliance in a sector where referral sources and payers are highly sensitive to outcomes. Second, it seeks to deepen local referral relationships with hospitals, physicians, skilled nursing facilities, and other discharge sources. Third, it is trying to improve labor productivity and staffing stability, which directly affect capacity, costs, and patient experience. Fourth, it is using hospice expansion, especially de novo branches, to add a second growth engine that can benefit from overlap with existing home health markets. The model is less about product innovation and more about operational excellence, local market density, and disciplined execution.
1d. What capabilities must Enhabit have in place?

To win, Enhabit needs strong recruiting and retention of nurses, therapists, aides, and hospice clinicians; disciplined branch leadership; effective local sales management; compliant clinical documentation and coding; and solid revenue cycle execution. Because home health and hospice are labor-intensive, the ability to recruit, onboard, schedule, and retain field clinicians is one of the company’s most important capabilities. It also needs analytics around referrals, admissions conversion, productivity, case mix, and payer economics.
1e. What management systems does Enhabit require?

Enhabit needs management systems that tightly track branch-level admissions, census, clinician productivity, visit utilization, labor costs, quality scores, and cash collection. In practical terms, that means operating rhythms around referral conversion, staffing levels, case capacity, documentation quality, reimbursement compliance, and de novo branch ramp-up. For a company like Enhabit, strategy execution is inseparable from branch management systems: if local teams cannot recruit clinicians, admit patients quickly, and document care correctly, national strategy will not translate into results.

2. What Are the Current Strategic Initiatives of Enhabit?

Based on Enhabit’s FY2024 public disclosures and management commentary in 2024 and early 2025, the company’s current strategic initiatives are focused on operational recovery and selective expansion rather than dramatic portfolio moves.

Reaccelerating home health admissions and census. Management has repeatedly highlighted the need to improve home health growth. That includes better referral conversion, stronger local sales execution, and enough clinical staffing to accept more patients. This matters because home health remains the larger business and a key driver of branch fixed-cost absorption.
Expanding and maturing the hospice footprint. Enhabit has continued to treat hospice as an important growth area. Public commentary has emphasized de novo hospice development and maturing newer locations. Hospice can be attractive strategically because it deepens the company’s home-based care presence and may benefit from referral overlap in markets where Enhabit already has home health operations.
Improving clinician recruiting, retention, and productivity. Staffing remains central. Enhabit has focused on reducing turnover, stabilizing field operations, and improving the productivity of clinicians and branch teams. In home health and hospice, workforce availability determines whether growth opportunities can actually be served.
Tightening labor and cost discipline. Enhabit has emphasized productivity, cost control, and operating efficiency. For a labor-heavy provider, small changes in visit productivity, contract labor usage, overtime, and case mix can materially affect margins.
Improving operational consistency. The company’s branch-based model means performance can vary by market. Management’s public focus on process discipline suggests a push toward more consistent execution in intake, admissions, clinical documentation, revenue cycle, and branch leadership.
Protecting liquidity and strengthening cash generation. As a relatively recently separated public company, Enhabit’s strategy has included attention to leverage, cash flow, and disciplined capital allocation. That has tended to favor operational improvement and measured de novo investment over aggressive large-scale acquisitions.

3. What Is the Business Model of Enhabit?

Enhabit is a home-based care services company. Customers do not buy a packaged product; they buy episodes or periods of clinically supervised care delivered in patients’ homes. In home health, the company is paid to provide skilled nursing, physical therapy, occupational therapy, speech therapy, medical social services, and home health aide services under physician-directed plans of care. In hospice, it is paid to manage end-of-life care, symptom control, nursing support, social work, chaplain services, bereavement support, and coordination of related services.

The revenue model is heavily reimbursement-driven. Traditional Medicare is a major payer. Home health reimbursement is largely shaped by the Patient-Driven Groupings Model, under which payment depends on patient characteristics, case mix, and utilization rules for 30-day periods of care, with some low-utilization situations effectively paid on a per-visit basis. Hospice is largely reimbursed on a per diem basis, with rates varying by level of care. Medicare Advantage and other non-Medicare payers are negotiated contracts.

The model is partly recurring and partly episodic. Individual home health episodes are discrete, but referral relationships, readmissions, and recertifications can make demand repeat-driven. Hospice revenue is generally tied to average daily census, which gives it a more recurring feel while patients remain on service. Pricing power is limited in traditional Medicare because government rates drive economics. Enhabit has more room to negotiate with Medicare Advantage and commercial plans, but even there pricing is constrained by local competition and network dynamics.

Business mix matters because home health and hospice have different operating rhythms. Home health is more sensitive to referral conversion, clinician capacity, and reimbursement updates. Hospice can be attractive once local census reaches density, because fixed branch costs can be leveraged over a larger patient base. Margins are driven mainly by labor efficiency, branch density, payer mix, clinical documentation accuracy, and SG&A leverage. Cash generation can be strong when operations are stable because the business is relatively asset-light, but reimbursement timing, denials, and staffing disruptions can pressure working capital and earnings.

4. What Products and/or Services Does Enhabit Sell?

Enhabit sells two main categories of services:

Home health services. These include skilled nursing, physical therapy, occupational therapy, speech-language pathology, medical social services, and home health aide support delivered in the patient’s home. These services are typically used after hospitalization, surgery, illness, or functional decline.
Hospice services. These include end-of-life care, pain and symptom management, nursing, social work, chaplain and spiritual care, bereavement support, and coordination of medications, supplies, and durable medical equipment associated with the hospice plan of care.

Home health appears to be the larger segment by revenue and an important driver of Enhabit’s scale with health systems and referral sources. Hospice is strategically important because it expands the company’s presence in home-based care and can create attractive local economics when branches achieve sufficient census density.

There is not a major “legacy product versus new product” story here in the way there would be at a technology company. The more relevant distinction is between mature branch operations and newer or ramping hospice locations, as well as between traditional Medicare work and business written under Medicare Advantage or other payer arrangements.

5. What Are the Key Competitors or Peers of Enhabit?

Enhabit competes in fragmented local markets, so its competitive set includes both large national operators and many regional or community-based providers. Key peers and competitors include:

Amedisys. One of the most direct public-market peers in home health and hospice, with a large national footprint and deep relationships with referral sources and payers.
LHC Group / Optum. LHC Group, now part of UnitedHealth Group’s Optum, has long been a major home health and hospice operator and remains a significant competitive force in many markets.
CenterWell Home Health. Backed by Humana, CenterWell is an important competitor in home health and benefits from payer alignment and a broad care-at-home strategy.
AccentCare. A large private home health, hospice, and personal care operator that competes in a number of overlapping local markets.
Elara Caring. Another scaled private provider with home health, hospice, and personal care services across multiple states.
Addus HomeCare. Best known for personal care, but also a meaningful hospice operator and, in some markets, a relevant home-based care competitor.
BrightSpring Health Services / Adoration Home Health and Hospice. A diversified home and community-based services platform with overlap in hospice and home health.
VITAS Healthcare. A major hospice-focused operator, especially relevant on the hospice side rather than home health.
Aveanna Healthcare. More concentrated in private duty and pediatric services than Enhabit, but still a relevant home-based healthcare peer.
Local nonprofit, hospital-affiliated, and independent agencies. In many markets, Enhabit’s most immediate competition is local rather than national. These providers can have strong referral relationships and established community brands.

The competitive reality is highly local. National scale helps with systems, recruiting, and payer discussions, but admissions are still won branch by branch through clinical reputation, referral responsiveness, staffing capacity, and local market relationships.

6. What Is the Marketing Strategy of Enhabit?

Enhabit’s marketing strategy is best understood as a referral-development strategy rather than a mass-market advertising strategy. In home health and hospice, the most important “marketing” activities are relationship building with discharge planners, physicians, hospitals, skilled nursing facilities, senior living communities, case managers, and payers. The company needs to be visible and credible where care transitions are decided.

That means local field marketing and account management are more important than broad consumer brand campaigns. For hospice, community outreach and family-facing reputation matter somewhat more, because families may play a more active role in provider choice. But even there, referral relationships remain critical.

Marketing is probably a supporting capability, not Enhabit’s primary differentiator. The real differentiators are likely service availability, clinical quality, speed of intake, local responsiveness, and the ability to staff cases. In other words, the message and the operation have to match. In a business where a branch cannot accept a referred patient because staffing is constrained, good marketing alone does not create value.

7. What Are the Key Customer Segments of Enhabit?

Enhabit serves several distinct customer groups, and it is useful to separate patients, payers, and referral sources:

Home health patients. Typically older adults or other eligible patients recovering from hospitalization, surgery, chronic illness episodes, or functional decline who can receive care safely in the home.
Hospice patients and families. Patients with terminal illness who elect hospice, along with family members and caregivers who are central to the care decision and support process.
Payers. Traditional Medicare is a core economic customer. Medicare Advantage plans, Medicaid programs, commercial insurers, and other reimbursement sources also matter.
Referral sources. Hospitals, physicians, skilled nursing facilities, rehabilitation providers, senior living communities, and other healthcare professionals are often the most important channel partners because they influence or direct patient flow.

Enhabit is diversified across two service lines but still meaningfully exposed to the senior and Medicare population. That creates a favorable demographic backdrop, but it also means reimbursement policy and referral-network positioning matter disproportionately.

8. What Is the Sales Model of Enhabit?

Enhabit’s sales model is primarily direct and local. The company does not rely on retail distribution or broad e-commerce channels. Instead, it uses branch-based sales and account-management teams to build referral relationships in each market. Those teams call on hospitals, physicians, skilled nursing facilities, assisted living communities, and other healthcare organizations that can send patients needing home-based care.

Once a referral is received, intake, eligibility review, staffing availability, and admission speed become part of the sales process. In that sense, operations and sales are tightly linked. A branch with better clinical staffing and faster intake can convert more referrals into admissions.

The channel structure affects growth in several ways. It increases customer intimacy because sales is relationship-led and local. It limits pricing power in Medicare but can support better contracting outcomes with managed-care payers when Enhabit has local credibility and capacity. It also creates clear consulting opportunities in areas such as territory design, referral-source segmentation, salesforce productivity, intake conversion analytics, and local-market growth planning.

9. In What Geographies Does Enhabit Operate?

Enhabit operates in the United States and, as of FY2024, served patients across 34 states. The company’s model is branch-based, so what matters most is not just the number of states but the density and effectiveness of local operations within each market.

Its operations consist of home health and hospice locations, supported by corporate functions headquartered in Dallas. The footprint gives Enhabit broad U.S. exposure, but it is not a fully national provider in every metro area. Like many home health and hospice companies, it appears stronger in selected regional clusters where it has built referral relationships and operating history over time.

From a strategic standpoint, Enhabit is geographically diversified enough to avoid dependence on a single state, yet still concentrated enough that branch-level execution in core regions can materially affect results. Geographic reach helps with payer relationships and recruiting scale, but the economics remain local.

10. Who Are the Owners of Enhabit?

Enhabit is a publicly traded company listed under the ticker EHAB. Ownership appears widely held, with no controlling shareholder disclosed in the company’s public materials. As is typical for a U.S. public company of its size, ownership is largely institutional. Public filings in 2025 showed large asset managers such as BlackRock and Vanguard among significant shareholders.

The company was created through a spin-off from Encompass Health in July 2022, after which Enhabit became independently owned by public shareholders.

11. How Is Enhabit Organized?

Enhabit is organized as a public holding company with operations carried out through licensed healthcare subsidiaries. From a reporting perspective, it has two official business segments: Home Health and Hospice.

Operationally, the business is organized around local branches and care teams. Those branches handle clinical delivery, referral development, and local market relationships. Corporate functions support the field with finance, compliance, legal, IT, human resources, revenue cycle, and other shared services.

The practical structure matters. Enhabit is not managed like a centralized digital platform where one system serves all customers identically. It is managed more like a network of regulated local care operations that must meet common quality, compliance, and financial standards while adapting to local labor markets and referral ecosystems.

12. How Does Enhabit Operate?

On a day-to-day basis, Enhabit operates by converting referrals into patient admissions, delivering in-home clinical care, documenting that care for compliance and reimbursement, and then billing and collecting from government and managed-care payers.

In home health, the process typically starts with a referral from a hospital, physician, or other provider. Enhabit verifies eligibility, assesses the patient, develops a plan of care, schedules home visits, and delivers nursing and therapy services over a defined episode or certification period. Clinical documentation, coding accuracy, Outcomes and Assessment Information Set (OASIS) quality, and physician order management are critical because they affect both compliance and reimbursement.

In hospice, the company manages an interdisciplinary care model. Nurses, social workers, chaplains, aides, and other team members support patients and families, coordinate medications and durable medical equipment, and provide bereavement support. Hospice operations depend heavily on census management, service responsiveness, and care coordination.

The biggest operational drivers are clinician availability, productivity, travel efficiency, referral response time, documentation quality, payer authorization workflows, and branch leadership. The biggest bottlenecks tend to be labor shortages, reimbursement complexity, and the challenge of keeping local execution consistent across a multi-state footprint.

13. What Are the Growth Opportunities for Enhabit?

Enhabit’s most plausible growth opportunities are visible and fairly practical rather than speculative.

Recovering home health volume. If Enhabit can continue improving staffing, referral conversion, and branch execution, home health admissions and census can recover from post-spin disruptions and become a more reliable growth engine.
Expanding hospice. Management has publicly emphasized hospice development, especially de novo growth. This remains one of the clearest opportunities because hospice broadens the platform and can produce attractive unit economics once local census builds.
Benefiting from home-based care trends. Healthcare systems and payers continue to push more care into lower-cost settings. That macro shift supports home health and hospice demand over time.
Improving payer mix and contract economics. Better managed-care contracting, stronger network positioning, and more disciplined case selection could improve economics, especially outside traditional fee-for-service Medicare.
Driving branch productivity. Growth does not have to come only from more branches. Enhabit can grow through better productivity, lower turnover, denser routes, stronger intake conversion, and more effective field leadership.
Selective M&A over time. While Enhabit’s recent posture has been more operationally focused, tuck-in acquisitions or market densification deals could become more relevant if leverage and execution improve.

Main constraints include clinician availability, annual reimbursement pressure from the Centers for Medicare & Medicaid Services, Medicare Advantage rate negotiations, compliance risk, and the difficulty of scaling local execution consistently across many markets.

14. What Is the History of Enhabit?

Enhabit became an independent public company on July 1, 2022, when Encompass Health separated its home health and hospice operations from its inpatient rehabilitation hospital business. That spin-off created a standalone company focused entirely on home-based care.

The business itself is older than the 2022 spin-off. Enhabit’s operating platform was built over time inside Encompass Health through acquisitions and branch development in home health and hospice. The current company therefore has a relatively recent public-company history, but its field operations and market relationships have deeper roots.

The spin created both opportunity and pressure. On the one hand, Enhabit gained a focused strategy and management attention tailored to home-based care. On the other hand, it had to establish itself as a standalone public company while navigating labor shortages, reimbursement complexity, and the need to rebuild growth and margin consistency after the separation.

15. What Is the Talent Strategy of Enhabit?

Talent is one of Enhabit’s most important strategic variables. In home health and hospice, the constraining resource is often not demand; it is the availability of licensed clinicians and effective local leaders. Public commentary since the spin-off has repeatedly underscored recruiting, retention, and productivity as core management priorities.

Enhabit’s talent strategy appears to center on five needs: hiring nurses and therapists in competitive local markets, retaining existing clinicians, stabilizing branch leadership, improving sales-force effectiveness, and giving teams the training and systems needed to work productively. Because care is delivered in the field, travel burden, scheduling efficiency, case assignment, and documentation workload all affect retention.

This makes talent more than an HR issue. It is a direct growth and margin issue. A branch that cannot recruit clinicians will lose admissions. A branch with unstable leadership will usually struggle on quality, productivity, and referral relationships. For Enhabit, talent is both a competitive differentiator and a major operating constraint.

16. What Is the Finance Strategy of Enhabit?

Enhabit’s finance strategy is shaped by the economics of an asset-light but labor-intensive healthcare services business. The company does not need large amounts of capital for factories or equipment, but it does need disciplined working capital management, prudent leverage, and careful capital allocation in a reimbursement-driven industry.

Since becoming independent, management’s public emphasis has been on improving profitability and cash flow, maintaining liquidity, and supporting the balance sheet while operational performance improves. That generally implies a finance agenda built around debt management, selective branch investment, measured hospice de novo expansion, and tight control of overhead and labor productivity.

Capital allocation has appeared more conservative than aggressive. In Enhabit’s current phase, the most value-accretive uses of capital are likely operational improvement, selective market expansion, and debt reduction rather than large-scale acquisitions or expansive shareholder returns. That is consistent with a company still sharpening standalone execution after a spin-off.

17. What Major Acquisitions Has Enhabit Made?

As an independent public company, Enhabit had not announced a large transformational acquisition through early 2025. Its recent strategy has been more focused on organic improvement and selective de novo growth, particularly in hospice, than on major M&A.

The more important portfolio-shaping transaction for understanding Enhabit is historical: the home-based care platform that became Enhabit was assembled inside Encompass Health, including prior acquisitions before the 2022 spin-off. The most important predecessor deal was HealthSouth’s 2014 acquisition of Encompass Home Health and Hospice, which became the foundation of the business later separated as Enhabit.

So the right way to think about M&A is this: large acquisitions have been important to the platform’s history, but not to Enhabit’s near-term post-spin playbook. In the current phase, management appears more focused on operating execution, staffing, margin recovery, and carefully chosen de novo expansion.

18. How Companies Like Enhabit Leverage Independent Consultants through Umbrex

Umbrex has grown a global community of over 8,000 independent management consultants who are based in more than 50 countries. These consultants are alums of McKinsey, Bain, BCG, and other top consulting firms. Companies like Enhabit engage Umbrex when they need talent with the training these top global firms provide but they do not need a full team with all the overhead. Umbrex has consultants across Strategy, Operations, Organization, Marketing, Sales, Finance, Technology, ERP, and AI.

For a company like Enhabit, the most relevant uses tend to be tightly scoped, execution-oriented projects tied to growth recovery, labor productivity, payer economics, and branch performance. Representative projects include:

Home health branch turnaround. Diagnose why selected branches are underperforming on referrals, admissions, staffing, or margins, and build a 90- to 180-day improvement plan.
Referral-source segmentation and sales redesign. Rework territory design, call patterns, account prioritization, and referral analytics for local market growth.
Hospice de novo market selection. Evaluate where Enhabit has enough referral density, labor availability, and payer attractiveness to open additional hospice locations.
Clinician workforce strategy. Improve recruiting funnels, onboarding, field productivity, caseload design, and retention economics for nurses and therapists.
Intake and admissions conversion improvement. Map the referral-to-admission workflow, identify leakage points, and redesign handoffs among sales, intake, staffing, and branch operations.
Managed-care and Medicare Advantage contract economics. Analyze payer profitability by market, service line, and branch, and support negotiation strategy.
Revenue cycle and documentation optimization. Improve coding accuracy, denial management, authorization workflows, and cash conversion.
SG&A and shared-services redesign. Review what should be centralized versus left in the field, with a focus on preserving local responsiveness while reducing overhead.
Post-spin operating model refinement. Clarify decision rights, performance dashboards, and branch-management routines to improve consistency across regions.
AI and automation use-case assessment. Evaluate practical uses of AI in scheduling, referral triage, clinical documentation support, recruiting analytics, and management reporting.